This protocol is judged by an institutional evaluation board, an unbiased group that reviews any clinical trials involving individuals. If a analyze will involve a Schedule I drug, once the board approves the protocol as ethical, the researchers need to submit an application for an investigational new drug (IND) number in the FDA.A session, which l